【News】The prime minister approved HAL therapy for mixed billing in National Strategic Special Zone

The proposal in the regional plan of Tokyo National Strategic Special Zone, which was resolved in the second conference for it on December 9, 2014 [See our “News” dd. Dec. 9.] was accredited upon approval of the prime minister. The regional plan includes preferential measures in terms of “special or specified medical care coverage” (so-called “mixed billings” for treatment fees partially covered and uncovered by insurance) for therapeutic treatments with HAL^® for recovering bodily motor functions. Details are as below [extract from the website of the prime minister’s office].

Name of enterprise: target enterprises for preferential measures in terms of special or specified medical care coverage

Content of enterprise: preferential measures in terms of special or specified medical care coverage

[Enterprises regulated by ordinances and others ordained by Article 26 concerning national strategic special zones] The law enables the medical institution listed below to use pharmaceuticals and others, or conduct all medical treatments with such pharmaceuticals and others, which have been approved by the authorities of USA, UK, France, Germany, Canada or Australia but have not been approved by the Japanese authority, applying “preferential measures in terms of special or specified medical care coverage”.

Name of medical institution: University Tokyo Hospital